By Nick Malinowski ( January 22, 2010, 6:37 PM EST) -- The Alabama Supreme Court has refused to reconsider its reversal of two jury decisions that had awarded the state nearly $275 million from Novartis Pharmaceuticals Corp., GlaxoSmithKline and AstraZeneca LP, putting to rest the bellwether prescription drug price-fixing case....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.